---
figid: PMC5823664__oncotarget-09-9540-g001
figlink: /pmc/articles/PMC5823664/figure/F1/
number: F1
caption: DNA sequence alterations including gene mutation/deletion/amplification,
  gene fusion, and epigenetic modification as well as regulatory mutation result in
  activation of multiple signaling pathways, which contribute to GBM development.
  Traditional targeted therapies are using inhibitors targeting the signaling pathways.
  However, novel therapeutic strategies are signaling pathway independent. Gene therapy,
  immunotherapy, stem cell therapy and CRISPR/Cas9 technology aim to deliver a gene
  to produce toxicity to cancer cells or cause cancer cell apoptosis, enhance host
  immune responses, and correct the mutated genome, which consequently will reduce/cure
  GBM.
pmcid: PMC5823664
papertitle: 'Glioblastoma: new therapeutic strategies to address cellular and genomic
  complexity.'
reftext: Xue Cai, et al. Oncotarget. 2018 Feb 6;9(10):9540-9554.
pmc_ranked_result_index: '7274'
pathway_score: 0.6597019
filename: oncotarget-09-9540-g001.jpg
figtitle: 'Glioblastoma: new therapeutic strategies to address cellular and genomic
  complexity'
year: '2018'
organisms: Homo sapiens
ndex: db03ee75-df10-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5823664__oncotarget-09-9540-g001.html
  '@type': Dataset
  description: DNA sequence alterations including gene mutation/deletion/amplification,
    gene fusion, and epigenetic modification as well as regulatory mutation result
    in activation of multiple signaling pathways, which contribute to GBM development.
    Traditional targeted therapies are using inhibitors targeting the signaling pathways.
    However, novel therapeutic strategies are signaling pathway independent. Gene
    therapy, immunotherapy, stem cell therapy and CRISPR/Cas9 technology aim to deliver
    a gene to produce toxicity to cancer cells or cause cancer cell apoptosis, enhance
    host immune responses, and correct the mutated genome, which consequently will
    reduce/cure GBM.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - WNT9B
  - MAPK12
  - WNT2B
  - MAP2K2
  - MAPK11
  - MAPK9
  - MAPK10
  - WNT9A
  - WNT5A
  - ARAF
  - WNT11
  - MAPK13
  - MAPK8
  - WNT4
  - WNT1
  - MAPK3
  - WNT3
  - WNT5B
  - WNT6
  - WNT2
  - AKT3
  - AKT1
  - AKT2
  - WNT10B
  - PIK3CG
  - WNT10A
  - PIK3CD
  - PIK3R3
  - PIK3CA
  - RAF1
  - BRAF
  - PIK3CB
  - MAPK14
  - MAPK1
  - TP53
  - WNT16
  - WNT8A
  - HRAS
  - WNT7A
  - WNT7B
  - PIK3R5
  - PIK3R6
  - KRAS
  - TGFB1
  - TGFB3
  - WNT8B
  - PIK3R4
  - TGFB2
  - WNT3A
  - NRAS
  - MTOR
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: RAS/RAF/MEK/MAPK,
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: RAS/RAF/MEK/MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: RAS/RAF/MEK/MAPK,
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS/RAF/MEK/MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: RAS/RAF/MEK/MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RAS/RAF/MEK/MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: RAS/RAF/MEK/MAPK,
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: RAS/RAF/MEK/MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: RAS/RAF/MEK/MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: RAS/RAF/MEK/MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS/RAF/MEK/MAPK,
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: RAS/RAF/MEK/MAPK,
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAS/RAF/MEK/MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAS/RAF/MEK/MAPK,
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: RAS/RAF/MEK/MAPK,
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS/RAF/MEK/MAPK,
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: TGFB,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGFB,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: TGFB,
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: RB,P53,Wnt,TGFB,UPRpathways
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: RAS/RAF/MEK/MAPK,
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K/AKT/MTOR,RAS/RAF/MEK/MAPK,
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5823664__F1
redirect_from: /figures/PMC5823664__F1
figtype: Figure
---
